BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26186629)

  • 41. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
    J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimal decongestive therapy in acute decompensated heart failure syndromes: far from being solved.
    Núñez J; Núñez E; Bodí V; Bayés-Genís A; Sanchis J
    Int J Cardiol; 2014 Jun; 174(2):457-8. PubMed ID: 24767134
    [No Abstract]   [Full Text] [Related]  

  • 43. Perioperative renal protection in patients with obstructive jaundice using drug combinations.
    Wahbah AM; el-Hefny MO; Wafa EM; el-Kharbotly W; el-Enin AA; Zaglol A; Atallah MM
    Hepatogastroenterology; 2000; 47(36):1691-4. PubMed ID: 11149033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.
    Stevens MA; McCullough PA; Tobin KJ; Speck JP; Westveer DC; Guido-Allen DA; Timmis GC; O'Neill WW
    J Am Coll Cardiol; 1999 Feb; 33(2):403-11. PubMed ID: 9973020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance.
    Palazzuoli A; Testani JM; Ruocco G; Pellegrini M; Ronco C; Nuti R
    Int J Cardiol; 2016 Dec; 224():213-219. PubMed ID: 27657476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Refractory acute decompensated heart failure: an observational study on a noninvasive hemodynamic monitoring system aimed at improving the therapeutic approach.
    Frea S; Franco E; Najd K; Panella S; Pinneri F
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):655-61. PubMed ID: 20308915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
    Okuhara Y; Hirotani S; Ando T; Nishimura K; Orihara Y; Komamura K; Naito Y; Mano T; Masuyama T
    Heart Vessels; 2017 Apr; 32(4):419-427. PubMed ID: 27469321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of diuretic treatment and sodium intake on plasma volume in patients with compensated systolic heart failure.
    Bonfils PK; Damgaard M; Taskiran M; Goetze JP; Norsk P; Gadsbøll N
    Eur J Heart Fail; 2010 Sep; 12(9):995-1001. PubMed ID: 20615919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Low dosage dopamine improves kidney function: current status of knowledge and evaluation of a controversial topic].
    Kindgen-Milles D; Tarnow J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Jun; 32(6):333-42. PubMed ID: 9333327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
    Allen LA; Turer AT; Dewald T; Stough WG; Cotter G; O'Connor CM
    Am J Cardiol; 2010 Jun; 105(12):1794-7. PubMed ID: 20538132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
    Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
    J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA
    Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of ibopamine in combination with furosemide on renal function in patients with chronic congestive heart failure.
    Vitolo E; Segalini G; Carini L; Castini D; Moreo A; Mazzola C; Segagni S; Villa G; Salvadeo A
    Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):327-34. PubMed ID: 3209280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diuretics in obstructive sleep apnea with diastolic heart failure.
    Bucca CB; Brussino L; Battisti A; Mutani R; Rolla G; Mangiardi L; Cicolin A
    Chest; 2007 Aug; 132(2):440-6. PubMed ID: 17699130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of Compound Hypertonic Saline Solution on Decompensated Heart Failure.
    Wan Y; Li L; Niu H; Ma X; Yang J; Yuan C; Mu G; Zhang J
    Int Heart J; 2017 Aug; 58(4):601-607. PubMed ID: 28701670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction.
    Takei M; Kohsaka S; Shiraishi Y; Goda A; Izumi Y; Yagawa M; Mizuno A; Sawano M; Inohara T; Kohno T; Fukuda K; Yoshikawa T;
    Circ Heart Fail; 2015 May; 8(3):527-32. PubMed ID: 25737498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.
    Gottlieb SS; Skettino SL; Wolff A; Beckman E; Fisher ML; Freudenberger R; Gladwell T; Marshall J; Cines M; Bennett D; Liittschwager EB
    J Am Coll Cardiol; 2000 Jan; 35(1):56-9. PubMed ID: 10636259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial.
    Llorens P; Miró Ò; Herrero P; Martín-Sánchez FJ; Jacob J; Valero A; Alonso H; Pérez-Durá MJ; Noval A; Gil-Román JJ; Zapater P; Llanos L; Gil V; Perelló R
    Emerg Med J; 2014 Sep; 31(9):706-13. PubMed ID: 23793945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.